Literature DB >> 16007716

Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasites.

Matthew P Glenn1, Sung-Youn Chang, Oliver Hucke, Christophe L M J Verlinde, Kasey Rivas, Carrie Hornéy, Kohei Yokoyama, Frederick S Buckner, Prakash R Pendyala, Debopam Chakrabarti, Michael Gelb, Wesley C Van Voorhis, Saïd M Sebti, Andrew D Hamilton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007716     DOI: 10.1002/anie.200500674

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  12 in total

1.  Diastereoselective addition of monoorganocuprates to a chiral fumarate: reaction development and synthesis of (-)-dihydroprotolichesterinic acid.

Authors:  J Caleb Hethcox; Charles S Shanahan; Stephen F Martin
Journal:  Tetrahedron       Date:  2015-09-16       Impact factor: 2.457

2.  Structurally simple, potent, Plasmodium selective farnesyltransferase inhibitors that arrest the growth of malaria parasites.

Authors:  Matthew P Glenn; Sung-Youn Chang; Carrie Hornéy; Kasey Rivas; Kohei Yokoyama; Erin E Pusateri; Steven Fletcher; Christopher G Cummings; Frederick S Buckner; Prakash R Pendyala; Debopam Chakrabarti; Saïd M Sebti; Michael Gelb; Wesley C Van Voorhis; Andrew D Hamilton
Journal:  J Med Chem       Date:  2006-09-21       Impact factor: 7.446

3.  Structures of Cryptococcus neoformans protein farnesyltransferase reveal strategies for developing inhibitors that target fungal pathogens.

Authors:  Michael A Hast; Connie B Nichols; Stephanie M Armstrong; Shannon M Kelly; Homme W Hellinga; J Andrew Alspaugh; Lorena S Beese
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

4.  Manumycin A Is a Potent Inhibitor of Mammalian Thioredoxin Reductase-1 (TrxR-1).

Authors:  Anupama Tuladhar; Kathleen S Rein
Journal:  ACS Med Chem Lett       Date:  2018-03-05       Impact factor: 4.345

5.  Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agents.

Authors:  Steven Fletcher; Erin Pusateri Keaney; Christopher G Cummings; Michelle A Blaskovich; Michael A Hast; Matthew P Glenn; Sung-Youn Chang; Cynthia J Bucher; Ryan J Floyd; William P Katt; Michael H Gelb; Wesley C Van Voorhis; Lorena S Beese; Said M Sebti; Andrew D Hamilton
Journal:  J Med Chem       Date:  2010-10-14       Impact factor: 7.446

6.  Isoprenoid biosynthesis inhibition disrupts Rab5 localization and food vacuolar integrity in Plasmodium falciparum.

Authors:  Ruth Howe; Megan Kelly; John Jimah; Dana Hodge; Audrey R Odom
Journal:  Eukaryot Cell       Date:  2012-12-07

7.  Potent, Plasmodium-selective farnesyltransferase inhibitors that arrest the growth of malaria parasites: structure-activity relationships of ethylenediamine-analogue scaffolds and homology model validation.

Authors:  Steven Fletcher; Christopher G Cummings; Kasey Rivas; William P Katt; Carrie Hornéy; Frederick S Buckner; Debopam Chakrabarti; Saïd M Sebti; Michael H Gelb; Wesley C Van Voorhis; Andrew D Hamilton
Journal:  J Med Chem       Date:  2008-08-08       Impact factor: 7.446

8.  Imidazole-containing farnesyltransferase inhibitors: 3D quantitative structure-activity relationships and molecular docking.

Authors:  Aihua Xie; Srinivas Odde; Sivaprakasam Prasanna; Robert J Doerksen
Journal:  J Comput Aided Mol Des       Date:  2009-05-29       Impact factor: 3.686

9.  Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferase.

Authors:  Michael A Hast; Steven Fletcher; Christopher G Cummings; Erin E Pusateri; Michelle A Blaskovich; Kasey Rivas; Michael H Gelb; Wesley C Van Voorhis; Said M Sebti; Andrew D Hamilton; Lorena S Beese
Journal:  Chem Biol       Date:  2009-02-27

10.  Protein Prenylation and Hsp40 in Thermotolerance of Plasmodium falciparum Malaria Parasites.

Authors:  Emily S Mathews; Andrew J Jezewski; Audrey R Odom John
Journal:  mBio       Date:  2021-06-29       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.